ENTITY

Halozyme Therapeutics (HALO US)

24
Analysis
Health CareUnited States
Halozyme Therapeutics, Inc. is a biopharmaceutical company developing products for the diabetes, cancer, dermatology and drug delivery markets. The Company's platform technology is based on recombinant human hyaluronidase plus additional enzymes. Halozyme applies its technology to its proprietary programs and to partnerships with pharmaceutical companies.
more
Company Event18 Feb 2026 13:00 • Upcoming
Add To Calendar
Company Event03 Dec 2025 02:20 • Latest
Company Event04 Nov 2025 05:30
Company Event06 Aug 2025 04:30
x